Transfasten
Payments companies reported to CMS as associated with Transfasten. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Transfasten, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Transfasten
These are the largest totals companies reported as associated with Transfasten. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Stewart Eidelson | New York, NY | Orthopaedic Surgery | $20,383.82 |
| Julian Cameron | Tamarac, FL | Orthopaedic Surgery of The Spine | $6,022.57 |
| Sabatino Bianco | Arlington, TX | Neurological Surgery | $1,916.25 |
| Terrence Julien | Tampa, FL | Neurology (Psychiatry & Neurology) | $250.36 |
| Faisal Siddiqui | Manassas, VA | Orthopaedic Surgery of The Spine | $175.63 |
| Marc Levine | Mercerville, NJ | Orthopaedic Surgery | $166.22 |
| Phillip Lim | Buena Park, CA | Interventional Pain Medicine | $161.11 |
| Harold Cordner | Sebastian, FL | Interventional Pain Medicine | $82.79 |
| John Afshar | West Palm Beach, FL | Neurological Surgery | $37.67 |
| Mark Grubb | Cleveland, OH | Orthopaedic Surgery | $27.13 |
Prescribed Transfasten?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.